Press Release August 30, 2021Dupixent® (dupilumab) pivotal trial meets all primary and secondary endpoints becoming first biologic medicine to significantly reduce signs and symptoms of moderate-to-severe atopic dermatitis in children as young as 6 months 0 0 Share
Press Release August 29, 2021ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages 360 DigiTech, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - QFIN 0 0 Share
Press Release August 29, 2021The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Katapult Holdings, Inc. (KPLT) Investors 0 0 Share
Press Release August 29, 2021FINAL DEADLINE TOMORROW: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Churchill Capital Corp IV n/k/a Lucid Group, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - LCID, CCIV 0 0 Share
Press Release August 29, 2021LAWSUITS FILED AGAINST YMM, YALA and PHG - Jakubowitz Law Pursues Shareholders Claims 0 0 Share
